Exchange Traded Concepts LLC grew its holdings in Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) by 219.4% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 18,921 shares of the company's stock after purchasing an additional 12,998 shares during the period. Exchange Traded Concepts LLC owned about 0.10% of Addus HomeCare worth $1,871,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently made changes to their positions in ADUS. Capital Research Global Investors acquired a new position in Addus HomeCare during the fourth quarter worth $51,149,000. American Century Companies Inc. lifted its position in Addus HomeCare by 695.8% during the fourth quarter. American Century Companies Inc. now owns 284,346 shares of the company's stock worth $35,643,000 after acquiring an additional 248,613 shares during the last quarter. GAMMA Investing LLC lifted its position in Addus HomeCare by 10,307.8% during the first quarter. GAMMA Investing LLC now owns 130,930 shares of the company's stock worth $12,948,000 after acquiring an additional 129,672 shares during the last quarter. Bank of America Corp DE lifted its position in Addus HomeCare by 273.6% during the fourth quarter. Bank of America Corp DE now owns 175,070 shares of the company's stock worth $21,945,000 after acquiring an additional 128,211 shares during the last quarter. Finally, TimesSquare Capital Management LLC lifted its position in Addus HomeCare by 28.5% during the fourth quarter. TimesSquare Capital Management LLC now owns 355,750 shares of the company's stock worth $44,593,000 after acquiring an additional 78,835 shares during the last quarter. 95.35% of the stock is currently owned by institutional investors and hedge funds.
Insider Transactions at Addus HomeCare
In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 2,045 shares of the firm's stock in a transaction that occurred on Tuesday, May 27th. The shares were sold at an average price of $115.00, for a total transaction of $235,175.00. Following the completion of the transaction, the executive vice president now owns 7,796 shares in the company, valued at approximately $896,540. This trade represents a 20.78% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 4.60% of the company's stock.
Addus HomeCare Price Performance
ADUS traded up $1.13 on Thursday, hitting $115.16. 115,269 shares of the stock were exchanged, compared to its average volume of 170,199. Addus HomeCare Corporation has a 12 month low of $88.96 and a 12 month high of $136.72. The business has a 50-day moving average of $108.65 and a two-hundred day moving average of $112.03. The company has a debt-to-equity ratio of 0.20, a current ratio of 1.74 and a quick ratio of 1.74. The firm has a market capitalization of $2.12 billion, a price-to-earnings ratio of 26.00, a PEG ratio of 1.63 and a beta of 0.81.
Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its quarterly earnings data on Monday, May 5th. The company reported $1.42 earnings per share for the quarter, topping the consensus estimate of $1.33 by $0.09. The business had revenue of $337.71 million during the quarter, compared to analysts' expectations of $341.66 million. Addus HomeCare had a net margin of 6.52% and a return on equity of 9.23%. Addus HomeCare's revenue was up 20.3% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.21 earnings per share. Sell-side analysts forecast that Addus HomeCare Corporation will post 4.59 EPS for the current fiscal year.
Analyst Ratings Changes
ADUS has been the topic of several research reports. Wall Street Zen downgraded shares of Addus HomeCare from a "buy" rating to a "hold" rating in a research note on Wednesday, February 26th. Macquarie restated an "outperform" rating and issued a $133.00 price target on shares of Addus HomeCare in a research note on Tuesday, June 10th. JMP Securities restated a "market outperform" rating and issued a $150.00 price target on shares of Addus HomeCare in a research note on Tuesday, April 22nd. Finally, Stephens restated an "overweight" rating and issued a $142.00 price target on shares of Addus HomeCare in a research note on Wednesday, March 12th. One equities research analyst has rated the stock with a hold rating, six have issued a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, Addus HomeCare currently has a consensus rating of "Buy" and an average price target of $142.57.
View Our Latest Report on Addus HomeCare
About Addus HomeCare
(
Free Report)
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Featured Stories

Before you consider Addus HomeCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.
While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.